SlideShare a Scribd company logo
MOF …. Continued.
SINTAYEHU (GSR1)
Clinical manifestations
 Does not occur as “a non or all rule”
 A range of organ dysfunction resulting in clinical organ failure
Post traumatic syndrome of MOF follows a predictable course
 Lung dysfunction precedes
 Cardiac by 0.6 days
 Hepatic by 4.8 days
 Renal by 5.5 days on average
 This sequential pattern is affected by pre-existing diseases or the nature of clinical event
Contd.
Clinical manifestation and temporal evolution of MOF is influenced by
 Host factors
 Advanced age
 Comorbid diseases
 Immunosuppressive drugs
 Genetic factors influence severity and progression
 genetic polymorphisms in genes controlling the synthesis of cytokines (eg, TNF,
IL-10) or TLR receptors manifest an excessive inflammatory response to acute
injury or sepsis …… higher risk for MODS
 Early MOF usually manifests within first 72hrs of the physiologic insult in
one of these ways
 Physiologic derangement
 Need for specific organ supportive therapy
 Separate clinical syndrome
Pulmonary dysfunction:
ARDS
 Acute respiratory failure with formation of non-cardiogenic PE
 reduced lung compliance and hypoxaemia which is refractory to oxygen
therapy.
 Characterized by
 Diffuse pulmonary infiltrates seen on CXR
 Pulmonary wedge pressure of < 18mmHg,
 PaO2/FiO2 ratio of < 26.6 kPa (200 mmHg)
 Causes of ARDS
 Direct
 Pulmonary insults
 Lung contusion, pneumonia, smoke inhalation etc.
 Indirect
 Severe extra pulmonary diseases like bacteremia, trauma, pancreatitis
 Two phases
 Initiator: release of pro-inflammatory mediators
 Effector phase: activated leukocytes release proteolytic enzymes and
ROS…..degradation of components of basement membrane……alveolar
flooding and surfactant deactivation
management
 Predisposing insult
 Nutritional support
 Low tidal volume MV
 Prognosis
 MR 50-60% and when with sepsis, MR increases to 90%
Ventilator induced lung injury
 VILI develops during treatment of ARDS and fuels failure of other organs
 Characterized by
 PaO2/FIO2 200 to 300
 May or may not progress to ARDS
Hepatic dysfunction
Circulatory shock
Hepatic
hypoperfusion
Ischemic hepatic injury
Gut derived cathecolamines
activate adrenoceptors on
kupffer cells
TNF and NO production
Acute hepatic
dysfunction
Diffuse hepatic
inflammation
circulation
Lung
injury
1, Ischemic hepatitis or shock liver
Hepatic hypo perfusion decreased protein synthesis, lactate clearance,
gluconeogenesis and glycogenolysis
 Characterized by
 elevations in aminotransferase level, prothrombin time, INR
 Significant lactic acidosis
 Profound hypoglycemia
 Centrilobular necrosis on histology
 Successful reversal of the shock state with aggressive resuscitation often reverses
the biochemical abnormalities.
ICU jaundice
 Typically conjugated hyperbilirubinemia
 Develops days after the physiologic insult and more common
 Histologic features include intrahepatic cholestasis, steatosis, and Kupffer
cell hyperplasia
 Causes
 Ongoing ischemia
 TPN cholestasis
 Drug toxicity
 Damage to bile canaliculi by infla.mediators or bact.toxin
GI dysfunction
 Likely results from interacting effects of reduced regional blood flow,
impaired motility, and change in normal microbial flora
 Manifestations include
 Stress gastritis
 ileus and intolerance of enteral feeding,
 pancreatitis, and acalculous cholecystitis
 Stress bleeding frequency has decreased recently due to
 Improved resuscitation
 Stress ulcer prophylaxis
Renal dysfunction
 Reflected by
 Decrease in UOP <0.5ml/kg/hr
 Increased creatinine level
 Need for replacement therapy or dialysis
 Early onset: hypotension, decreased RBF
 Late onset: multifactorial
 Pre-renal factors like d CO and hypovolemia
 Nephrotoxic agents( drugs and radiocontrast)
 release of cytokines (TNF induces apoptosis of renal cells)
 Aggravated by vasoactive agents used in shock treatment
Metabolic dysfunction
 Severe physiologic stress induces a syndrome of metabolic alterations
termed hypermetabolic stress response
 Occurs in 60 to 65% of stressed patients
 Changes include:
Increased VO2
Hyperglycemia
Hyperlactatemia
Protein catabolism
 15 to 20% of patients have inappropriate hypometabolic response
Stratifying severity of stress to identify significant hypermetabolism
Adrenocortical insufficiency
 Serum cortisol inadequate for ongoing stress response
 Cytokine mediated decrease in synthesis or release of corticotropin releasing
hormone, ACTH or cortisol
 May also result from long term administration of glucocorticoids
 Characterized by
 Decreased SVR, CO and hypovolemia
 Considered in critically ill patients vasopressor dependent despite
adequate resuscitation and source control
 Dx
 Random serum cortisol<10micg/dl or increase <9micg/dl after 250micg/dl iv
ACTH stimulation test
Glucose disorders
Hyperglycemia
 Develops early following insult
 Causes
 Increased glycogenolysis and gluconeogenesis
 Due to increase in stress hormones
 ACTH,glucocorticoids, glucagon, cathecolamines and insulin resistance
Hypoglycemia occurs late
Depletion of glycogen store
Failure of gluconeogenesis in liver
Cardiovascular dysfunction
 Altered peripheral vascular and myocardial function in the absence of pre
existing dysfunction
 Clinically manifests with
 Peripheral edema with hypotension refractory to volume challenge
 Need for vasoactive agents to support circulation
 Early hyper dynamic phase
 Late hypo daynamic phase
 NO is implicated in both the peripheral vasodilatation and the myocardial
depression.
 Dilation of ventricles-----increase LVEDV…..maintain SV despite impaired
contractility
 Despite correction of macrovascular hemodynamic parameters, persistent
microvascular dysfunction is associated with organ dysfunction and death
 Endothelial activation mediated by Lectin-like
oxidized low-density lipoprotein receptor-1 (LOX-1) ….
 induces superoxide generation, and enhances endothelial
adhesiveness to leukocytes and chemokine production….endothelial dysfunction
……MODs
LOX_1 a novel target for modulation of inflammation in microcirculation
Neurologic dysfunction
 CNS dysfunction
 In 70% of critically ill patients
 Confusion, disorientation, decreased level of consciousness
Without focal signs
 Recently known to be independent predictor of poor out come
 Complex phenomenon involving
 Alteration of BBB
 Entry of circulating cytokines
 Endotoxemia stimulating local production of TNF by microglia and astrocytes
 TNF induces brain edema, neutrophil infiltration, astrocytosis, and apoptotic cellular death
PNS dysfunction (critical illness polyneuropathy)
 clinical presentation tends to be more subtle than that of CNS
 Diffuse weakness, depressed reflex, distal sensory loss
 Limb weakness with spared cranial nerves
 Suspected when failure of weaning from MV despite improvement of
underlying critical illness
 Pathology axonal degeneration
 Cause is not well understood
 Inflammatory mediators thought to play a role
 Preventable aspects
 Unnecessary and prolonged NM blockade
 Prolonged or high dose glucocorticoids
 Excessive propofol use
 Electrolyte abnormalities, glycemic control
Hematologic dysfunction
 DIC or Thrombohemorrhagic disorders
 Most fulminant hematologic dysfunction in MOF
 results from a massive activation of the clotting cascade
 Activation of hemostasis leading to formation of thrombin
 Compensatory thrombolysis( secondary fibrolysis)
 Degrade fibrinogen and other clotting factors, causing consumption
coagulopathy, exacerbating the bleeding diathesis
 Thrombocytopenia
the most common hematologic abnormality critical illness
-in 20% 0f all ICU pts
-causes
.↑sed consumption
.impaired thrombopoiesis from BM suppression
Others
Mild anemia
Leucopenia from overwhelming inflammatory stimulus
Laboratory examinations
 No specific test for MODs
 Abnormalities in the following tests are commonly seen
 Acid-base: d anion gap ….associated with increased mortality
 CBC: normocytic anemia, high or low WBC, thrombocytopenia
 LFTs insensitive to diagnose early liver dysfunction in MODs
 Serum albumin: in MODs hypoalbuminemia results from cytokine induced
suppression of synthesis, albumin catabolism, dilutional and 3rd space losses.
Adverse px but poor sensitivity and specificity
 Procalcitonin: plasma marker of sepsis. Septic vs nonseptic, not specific
Hemodynamic monitors of tissue
perfusion
 Global
 SvO2/ ScvO2>70%
 Esophageal Doppler probe…measure CO during resuscitation after
trauma
 Regional perfusion
 Gastric tonometry PHi and PCO2
 Siblingual capnometry
Modifiable
 Delay in resuscitation
 Amount of RBC transfusion
 Age of transfused products
 High base deficit
 Uncorrected lactate at 12-
24hrs post injury
 Abdominal compartment
syndrome
 Missed injury
Non modifiable
 High injury severity
 Age >55years old
 Obesity
 Male gender
 Genetics
 Comorbidities
Predictors of MOF
Biomarker Disease conditions Role
Neutrophil gelatinase-
Lipocalin (NGAL)
acute kidney injury Detects 36-48hrs earlier
than creatinine
Serum glutamate/glutamine Sepsis Marks liver dysfunction
Cytokeratin-18 (CK-18) Sepsis with hepatic dysfunction Early predictor of survival
Procalcitonin (PCT) Sepsis and infection Early marker
Adrenomedullin (AM) Acute cardiac injury Elevated in early septic
shock
Pentraxin-3 (PTX3) Acute lung and heart injury Correlate with severity
NT-pro-BNP severe sepsis and septic shock Marks myocardial
dysfunction
VCAM-1(vascular cell adhesion
molecule 1)
Mediates adhesion of cells to
endothelium
Cytokines (interleukine; IL) 6 Myocardial disfunction Predictor of mortality
Endothelial cell-specific
molecule 1
(ESM-1
sepsis Endocan increase indicate
poor prognosis
Scoring of MOF
 No gold standard system
Most organ failure assessment systems assign values to six organ systems
 Respiratory
 Cardiovascular
 Renal
 Hematology,
 Hepatic
 Central nervous system
 Sauaia et al. reported Denver and Marshall MODS perform well as
indicators of unfavorable outcomes in critically ill patients
Marshall MOF scores
 Evaluate 6 systems each scored 0-4
 Parameters recorded at same time of day always
 Does not consider specific values as indicators of MOF
 Establishes degree of severity defined by observed mortality
 Denver scale evaluates
 4 systems each scored 0-3
 OF defined as score>0 , MOF is defined as failure of 2 or more organs with
score of 4 or more as determined 48hrs after trauma
Ciesla et al, The role of the lung in postinjury multiple organ failure Surgery 01-OCT-2005;
138(4): 749-57
Management principles
 Early aggressive resuscitation and physiologic monitoring
 Avoid additional insults and control sources
 Prevent nosocomial infection
 Supportive therapy for dysfunctional organ
 Glycemic control and early enteral nutrition
 Prophylaxis: DVT , Stress ulcer
 Minimize blood transfusion when possible
 Use agents that can disrupt end organ injury
 Activated protein C
Current Therapy of Trauma and Surgical Critical Care eds Asensio and Trunkey
2008
Prognosis of MOF
Depends on
 Number of failing organs
 MR 27-100%
 Duration of organ dysfunction
 Advanced age
 Premorbid illness
Knaus
References
 Mastery of Surgery, 5th Edition
 ACS surgery: principles and practices, 2007 edition
 Subston text book of surgery, 19th edition
 International Journal of Clinical Medicine, 2012, 3, 722-730
 de Montmollin and Annane Critical Care2011, 15:236
 Can J Surg, Vol. 51, No. 2, April 2008
 EDWIN A. DEITCH, M.D.
Thank you

More Related Content

What's hot

Acute hemolytic anemia
Acute hemolytic anemiaAcute hemolytic anemia
Acute hemolytic anemia
MohamedEid822594
 
Chronic myeloid leukemia magdi sasi 2019 ramadan
Chronic myeloid leukemia magdi sasi 2019 ramadanChronic myeloid leukemia magdi sasi 2019 ramadan
Chronic myeloid leukemia magdi sasi 2019 ramadan
cardilogy
 
Addison
AddisonAddison
Addison
Hazem Samy
 
Pancytopenia
PancytopeniaPancytopenia
Pancytopenia
LWCH, UAE
 
Acute liver failure in icu
Acute liver failure in icuAcute liver failure in icu
Acute liver failure in icu
Wahid altaf Sheeba hakak
 
Hematological emergencies 2
Hematological emergencies 2Hematological emergencies 2
Hematological emergencies 2
ajayyadav753
 
Sle complication
Sle complicationSle complication
Sle complication
Marwa Besar
 
Liver acute liver failure 15 01 14
Liver acute liver failure 15 01 14Liver acute liver failure 15 01 14
Liver acute liver failure 15 01 14
Rajendran Surendran
 
Acute liver failure
Acute liver failureAcute liver failure
Acute liver failure
Suresh Gorka
 
Chronic leukemias csbrp
Chronic leukemias csbrpChronic leukemias csbrp
Chronic leukemias csbrp
Prasad CSBR
 
Role of phlebotomy in copd
Role of phlebotomy in copdRole of phlebotomy in copd
Role of phlebotomy in copd
Dr Shami Bhagat
 
Acute Liver Failure Update
Acute Liver Failure UpdateAcute Liver Failure Update
Acute Liver Failure Update
Palepu BN Gopal
 
Sub acute hepatic failure
Sub acute hepatic failureSub acute hepatic failure
Sub acute hepatic failureSarath Menon
 
Enfermedad de addison_johanna acosta
Enfermedad de addison_johanna acostaEnfermedad de addison_johanna acosta
Enfermedad de addison_johanna acostanoah122
 
Myeloproliferative neoplasms 2
Myeloproliferative neoplasms 2Myeloproliferative neoplasms 2
Myeloproliferative neoplasms 2
ajayyadav753
 
Drug induced bleeding disorders
Drug induced bleeding disordersDrug induced bleeding disorders
Drug induced bleeding disordersNagesh Pandit
 
Adrenal insufficiency 2015
Adrenal insufficiency    2015Adrenal insufficiency    2015
Adrenal insufficiency 2015
samirelansary
 
Polycythemia.
Polycythemia.Polycythemia.
Polycythemia.
Ruhul Amin
 
Hematology Rivas2008 Lecture4&5
Hematology Rivas2008 Lecture4&5Hematology Rivas2008 Lecture4&5
Hematology Rivas2008 Lecture4&5Miami Dade
 

What's hot (20)

Acute hemolytic anemia
Acute hemolytic anemiaAcute hemolytic anemia
Acute hemolytic anemia
 
Chronic myeloid leukemia magdi sasi 2019 ramadan
Chronic myeloid leukemia magdi sasi 2019 ramadanChronic myeloid leukemia magdi sasi 2019 ramadan
Chronic myeloid leukemia magdi sasi 2019 ramadan
 
Addison
AddisonAddison
Addison
 
Pancytopenia
PancytopeniaPancytopenia
Pancytopenia
 
Acute liver failure in icu
Acute liver failure in icuAcute liver failure in icu
Acute liver failure in icu
 
Hematological emergencies 2
Hematological emergencies 2Hematological emergencies 2
Hematological emergencies 2
 
Sle complication
Sle complicationSle complication
Sle complication
 
A Case of POEMS Syndrome
A Case of POEMS SyndromeA Case of POEMS Syndrome
A Case of POEMS Syndrome
 
Liver acute liver failure 15 01 14
Liver acute liver failure 15 01 14Liver acute liver failure 15 01 14
Liver acute liver failure 15 01 14
 
Acute liver failure
Acute liver failureAcute liver failure
Acute liver failure
 
Chronic leukemias csbrp
Chronic leukemias csbrpChronic leukemias csbrp
Chronic leukemias csbrp
 
Role of phlebotomy in copd
Role of phlebotomy in copdRole of phlebotomy in copd
Role of phlebotomy in copd
 
Acute Liver Failure Update
Acute Liver Failure UpdateAcute Liver Failure Update
Acute Liver Failure Update
 
Sub acute hepatic failure
Sub acute hepatic failureSub acute hepatic failure
Sub acute hepatic failure
 
Enfermedad de addison_johanna acosta
Enfermedad de addison_johanna acostaEnfermedad de addison_johanna acosta
Enfermedad de addison_johanna acosta
 
Myeloproliferative neoplasms 2
Myeloproliferative neoplasms 2Myeloproliferative neoplasms 2
Myeloproliferative neoplasms 2
 
Drug induced bleeding disorders
Drug induced bleeding disordersDrug induced bleeding disorders
Drug induced bleeding disorders
 
Adrenal insufficiency 2015
Adrenal insufficiency    2015Adrenal insufficiency    2015
Adrenal insufficiency 2015
 
Polycythemia.
Polycythemia.Polycythemia.
Polycythemia.
 
Hematology Rivas2008 Lecture4&5
Hematology Rivas2008 Lecture4&5Hematology Rivas2008 Lecture4&5
Hematology Rivas2008 Lecture4&5
 

Similar to Manifestations of mof

Sepsis – pathophysiology and management
Sepsis – pathophysiology and managementSepsis – pathophysiology and management
Sepsis – pathophysiology and managementVidhi Singh
 
Multiple organ dysfunction syndrome
Multiple organ dysfunction syndromeMultiple organ dysfunction syndrome
Multiple organ dysfunction syndrome
Olubayode Akinbi, M.D
 
Nephrotic syndrome final shivaom
Nephrotic syndrome final shivaomNephrotic syndrome final shivaom
Nephrotic syndrome final shivaom
Shivaom Chaurasia
 
Septic shock.pptx
Septic shock.pptxSeptic shock.pptx
Septic shock.pptx
OdjugoEretare
 
Approach to hypovolemic and septic shock
Approach to hypovolemic and septic shockApproach to hypovolemic and septic shock
Approach to hypovolemic and septic shock
Ahmed Bahamid
 
Multiple organ dysfunction syndrome
Multiple organ dysfunction  syndromeMultiple organ dysfunction  syndrome
Multiple organ dysfunction syndrome
Mayur Rath
 
sepsis.pptx
sepsis.pptxsepsis.pptx
sepsis.pptx
Aditya Raghav
 
Strategizing SIRS in nutrition
Strategizing SIRS in nutritionStrategizing SIRS in nutrition
Strategizing SIRS in nutrition
tcrumph2
 
Mpn
MpnMpn
shock.pptx
shock.pptxshock.pptx
shock.pptx
sonalidas935894
 
Shock
ShockShock
Shock
rilaransi
 
7&8. SHOCK.pdf new new w new w new w new be
7&8. SHOCK.pdf new new w new w new w new be7&8. SHOCK.pdf new new w new w new w new be
7&8. SHOCK.pdf new new w new w new w new be
SafinRoka
 
Get Into the Loop - Learn About Lupus
Get Into the Loop - Learn About Lupus Get Into the Loop - Learn About Lupus
Get Into the Loop - Learn About Lupus
LupusNY
 
Sepsis multiple organ dysfunction syndrome
Sepsis   multiple organ dysfunction syndromeSepsis   multiple organ dysfunction syndrome
Sepsis multiple organ dysfunction syndrome
konuku
 
sepsis .pptx
sepsis .pptxsepsis .pptx
sepsis .pptx
Revathy S
 
Rheumatology in ICU.pptx
Rheumatology in ICU.pptxRheumatology in ICU.pptx
Rheumatology in ICU.pptx
Mani Reddy
 
critical illness and metabolism ICRC 2012.pptx
critical illness and metabolism ICRC 2012.pptxcritical illness and metabolism ICRC 2012.pptx
critical illness and metabolism ICRC 2012.pptx
ssuser6aa7a3
 
Multiple Organ Dysfunction Syndrome (MODS).
Multiple Organ Dysfunction Syndrome (MODS).Multiple Organ Dysfunction Syndrome (MODS).
Multiple Organ Dysfunction Syndrome (MODS).
Pinky Rathee
 

Similar to Manifestations of mof (20)

Sepsis – pathophysiology and management
Sepsis – pathophysiology and managementSepsis – pathophysiology and management
Sepsis – pathophysiology and management
 
Multiple organ dysfunction syndrome
Multiple organ dysfunction syndromeMultiple organ dysfunction syndrome
Multiple organ dysfunction syndrome
 
Nephrotic syndrome final shivaom
Nephrotic syndrome final shivaomNephrotic syndrome final shivaom
Nephrotic syndrome final shivaom
 
Septic shock.pptx
Septic shock.pptxSeptic shock.pptx
Septic shock.pptx
 
Approach to hypovolemic and septic shock
Approach to hypovolemic and septic shockApproach to hypovolemic and septic shock
Approach to hypovolemic and septic shock
 
Multiple organ dysfunction syndrome
Multiple organ dysfunction  syndromeMultiple organ dysfunction  syndrome
Multiple organ dysfunction syndrome
 
sepsis.pptx
sepsis.pptxsepsis.pptx
sepsis.pptx
 
Strategizing SIRS in nutrition
Strategizing SIRS in nutritionStrategizing SIRS in nutrition
Strategizing SIRS in nutrition
 
shock
shockshock
shock
 
Mpn
MpnMpn
Mpn
 
shock.pptx
shock.pptxshock.pptx
shock.pptx
 
Shock
ShockShock
Shock
 
7&8. SHOCK.pdf new new w new w new w new be
7&8. SHOCK.pdf new new w new w new w new be7&8. SHOCK.pdf new new w new w new w new be
7&8. SHOCK.pdf new new w new w new w new be
 
Get Into the Loop - Learn About Lupus
Get Into the Loop - Learn About Lupus Get Into the Loop - Learn About Lupus
Get Into the Loop - Learn About Lupus
 
Wilson disease etc
Wilson disease etcWilson disease etc
Wilson disease etc
 
Sepsis multiple organ dysfunction syndrome
Sepsis   multiple organ dysfunction syndromeSepsis   multiple organ dysfunction syndrome
Sepsis multiple organ dysfunction syndrome
 
sepsis .pptx
sepsis .pptxsepsis .pptx
sepsis .pptx
 
Rheumatology in ICU.pptx
Rheumatology in ICU.pptxRheumatology in ICU.pptx
Rheumatology in ICU.pptx
 
critical illness and metabolism ICRC 2012.pptx
critical illness and metabolism ICRC 2012.pptxcritical illness and metabolism ICRC 2012.pptx
critical illness and metabolism ICRC 2012.pptx
 
Multiple Organ Dysfunction Syndrome (MODS).
Multiple Organ Dysfunction Syndrome (MODS).Multiple Organ Dysfunction Syndrome (MODS).
Multiple Organ Dysfunction Syndrome (MODS).
 

More from Sintayehu Asrat

Flaps and grafts in plastic surgery
Flaps and grafts in plastic surgeryFlaps and grafts in plastic surgery
Flaps and grafts in plastic surgery
Sintayehu Asrat
 
Criteria for acceptable reduction of forearm fractures
Criteria for acceptable reduction of forearm fracturesCriteria for acceptable reduction of forearm fractures
Criteria for acceptable reduction of forearm fractures
Sintayehu Asrat
 
Peritonitis and intra abdominal abscess
Peritonitis and intra abdominal abscessPeritonitis and intra abdominal abscess
Peritonitis and intra abdominal abscess
Sintayehu Asrat
 
mechanical ventilation Weaning predictors
mechanical ventilation Weaning predictorsmechanical ventilation Weaning predictors
mechanical ventilation Weaning predictors
Sintayehu Asrat
 
Mechanical ventilation wave forms
Mechanical ventilation wave formsMechanical ventilation wave forms
Mechanical ventilation wave forms
Sintayehu Asrat
 
Pud presentation1
Pud presentation1Pud presentation1
Pud presentation1
Sintayehu Asrat
 
Luto
LutoLuto

More from Sintayehu Asrat (7)

Flaps and grafts in plastic surgery
Flaps and grafts in plastic surgeryFlaps and grafts in plastic surgery
Flaps and grafts in plastic surgery
 
Criteria for acceptable reduction of forearm fractures
Criteria for acceptable reduction of forearm fracturesCriteria for acceptable reduction of forearm fractures
Criteria for acceptable reduction of forearm fractures
 
Peritonitis and intra abdominal abscess
Peritonitis and intra abdominal abscessPeritonitis and intra abdominal abscess
Peritonitis and intra abdominal abscess
 
mechanical ventilation Weaning predictors
mechanical ventilation Weaning predictorsmechanical ventilation Weaning predictors
mechanical ventilation Weaning predictors
 
Mechanical ventilation wave forms
Mechanical ventilation wave formsMechanical ventilation wave forms
Mechanical ventilation wave forms
 
Pud presentation1
Pud presentation1Pud presentation1
Pud presentation1
 
Luto
LutoLuto
Luto
 

Recently uploaded

Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
drhasanrajab
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 

Recently uploaded (20)

Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 

Manifestations of mof

  • 2. Clinical manifestations  Does not occur as “a non or all rule”  A range of organ dysfunction resulting in clinical organ failure Post traumatic syndrome of MOF follows a predictable course  Lung dysfunction precedes  Cardiac by 0.6 days  Hepatic by 4.8 days  Renal by 5.5 days on average  This sequential pattern is affected by pre-existing diseases or the nature of clinical event
  • 3. Contd. Clinical manifestation and temporal evolution of MOF is influenced by  Host factors  Advanced age  Comorbid diseases  Immunosuppressive drugs  Genetic factors influence severity and progression  genetic polymorphisms in genes controlling the synthesis of cytokines (eg, TNF, IL-10) or TLR receptors manifest an excessive inflammatory response to acute injury or sepsis …… higher risk for MODS
  • 4.  Early MOF usually manifests within first 72hrs of the physiologic insult in one of these ways  Physiologic derangement  Need for specific organ supportive therapy  Separate clinical syndrome
  • 5. Pulmonary dysfunction: ARDS  Acute respiratory failure with formation of non-cardiogenic PE  reduced lung compliance and hypoxaemia which is refractory to oxygen therapy.  Characterized by  Diffuse pulmonary infiltrates seen on CXR  Pulmonary wedge pressure of < 18mmHg,  PaO2/FiO2 ratio of < 26.6 kPa (200 mmHg)
  • 6.  Causes of ARDS  Direct  Pulmonary insults  Lung contusion, pneumonia, smoke inhalation etc.  Indirect  Severe extra pulmonary diseases like bacteremia, trauma, pancreatitis  Two phases  Initiator: release of pro-inflammatory mediators  Effector phase: activated leukocytes release proteolytic enzymes and ROS…..degradation of components of basement membrane……alveolar flooding and surfactant deactivation
  • 7. management  Predisposing insult  Nutritional support  Low tidal volume MV  Prognosis  MR 50-60% and when with sepsis, MR increases to 90%
  • 8. Ventilator induced lung injury  VILI develops during treatment of ARDS and fuels failure of other organs  Characterized by  PaO2/FIO2 200 to 300  May or may not progress to ARDS
  • 9. Hepatic dysfunction Circulatory shock Hepatic hypoperfusion Ischemic hepatic injury Gut derived cathecolamines activate adrenoceptors on kupffer cells TNF and NO production Acute hepatic dysfunction Diffuse hepatic inflammation circulation Lung injury
  • 10. 1, Ischemic hepatitis or shock liver Hepatic hypo perfusion decreased protein synthesis, lactate clearance, gluconeogenesis and glycogenolysis  Characterized by  elevations in aminotransferase level, prothrombin time, INR  Significant lactic acidosis  Profound hypoglycemia  Centrilobular necrosis on histology  Successful reversal of the shock state with aggressive resuscitation often reverses the biochemical abnormalities.
  • 11. ICU jaundice  Typically conjugated hyperbilirubinemia  Develops days after the physiologic insult and more common  Histologic features include intrahepatic cholestasis, steatosis, and Kupffer cell hyperplasia  Causes  Ongoing ischemia  TPN cholestasis  Drug toxicity  Damage to bile canaliculi by infla.mediators or bact.toxin
  • 12. GI dysfunction  Likely results from interacting effects of reduced regional blood flow, impaired motility, and change in normal microbial flora  Manifestations include  Stress gastritis  ileus and intolerance of enteral feeding,  pancreatitis, and acalculous cholecystitis  Stress bleeding frequency has decreased recently due to  Improved resuscitation  Stress ulcer prophylaxis
  • 13. Renal dysfunction  Reflected by  Decrease in UOP <0.5ml/kg/hr  Increased creatinine level  Need for replacement therapy or dialysis  Early onset: hypotension, decreased RBF  Late onset: multifactorial  Pre-renal factors like d CO and hypovolemia  Nephrotoxic agents( drugs and radiocontrast)  release of cytokines (TNF induces apoptosis of renal cells)  Aggravated by vasoactive agents used in shock treatment
  • 14. Metabolic dysfunction  Severe physiologic stress induces a syndrome of metabolic alterations termed hypermetabolic stress response  Occurs in 60 to 65% of stressed patients  Changes include: Increased VO2 Hyperglycemia Hyperlactatemia Protein catabolism  15 to 20% of patients have inappropriate hypometabolic response Stratifying severity of stress to identify significant hypermetabolism
  • 15. Adrenocortical insufficiency  Serum cortisol inadequate for ongoing stress response  Cytokine mediated decrease in synthesis or release of corticotropin releasing hormone, ACTH or cortisol  May also result from long term administration of glucocorticoids  Characterized by  Decreased SVR, CO and hypovolemia  Considered in critically ill patients vasopressor dependent despite adequate resuscitation and source control  Dx  Random serum cortisol<10micg/dl or increase <9micg/dl after 250micg/dl iv ACTH stimulation test
  • 16. Glucose disorders Hyperglycemia  Develops early following insult  Causes  Increased glycogenolysis and gluconeogenesis  Due to increase in stress hormones  ACTH,glucocorticoids, glucagon, cathecolamines and insulin resistance Hypoglycemia occurs late Depletion of glycogen store Failure of gluconeogenesis in liver
  • 17. Cardiovascular dysfunction  Altered peripheral vascular and myocardial function in the absence of pre existing dysfunction  Clinically manifests with  Peripheral edema with hypotension refractory to volume challenge  Need for vasoactive agents to support circulation  Early hyper dynamic phase  Late hypo daynamic phase  NO is implicated in both the peripheral vasodilatation and the myocardial depression.  Dilation of ventricles-----increase LVEDV…..maintain SV despite impaired contractility
  • 18.  Despite correction of macrovascular hemodynamic parameters, persistent microvascular dysfunction is associated with organ dysfunction and death  Endothelial activation mediated by Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) ….  induces superoxide generation, and enhances endothelial adhesiveness to leukocytes and chemokine production….endothelial dysfunction ……MODs LOX_1 a novel target for modulation of inflammation in microcirculation
  • 19. Neurologic dysfunction  CNS dysfunction  In 70% of critically ill patients  Confusion, disorientation, decreased level of consciousness Without focal signs  Recently known to be independent predictor of poor out come  Complex phenomenon involving  Alteration of BBB  Entry of circulating cytokines  Endotoxemia stimulating local production of TNF by microglia and astrocytes  TNF induces brain edema, neutrophil infiltration, astrocytosis, and apoptotic cellular death
  • 20. PNS dysfunction (critical illness polyneuropathy)  clinical presentation tends to be more subtle than that of CNS  Diffuse weakness, depressed reflex, distal sensory loss  Limb weakness with spared cranial nerves  Suspected when failure of weaning from MV despite improvement of underlying critical illness
  • 21.  Pathology axonal degeneration  Cause is not well understood  Inflammatory mediators thought to play a role  Preventable aspects  Unnecessary and prolonged NM blockade  Prolonged or high dose glucocorticoids  Excessive propofol use  Electrolyte abnormalities, glycemic control
  • 22. Hematologic dysfunction  DIC or Thrombohemorrhagic disorders  Most fulminant hematologic dysfunction in MOF  results from a massive activation of the clotting cascade  Activation of hemostasis leading to formation of thrombin  Compensatory thrombolysis( secondary fibrolysis)  Degrade fibrinogen and other clotting factors, causing consumption coagulopathy, exacerbating the bleeding diathesis
  • 23.  Thrombocytopenia the most common hematologic abnormality critical illness -in 20% 0f all ICU pts -causes .↑sed consumption .impaired thrombopoiesis from BM suppression Others Mild anemia Leucopenia from overwhelming inflammatory stimulus
  • 24. Laboratory examinations  No specific test for MODs  Abnormalities in the following tests are commonly seen  Acid-base: d anion gap ….associated with increased mortality  CBC: normocytic anemia, high or low WBC, thrombocytopenia  LFTs insensitive to diagnose early liver dysfunction in MODs  Serum albumin: in MODs hypoalbuminemia results from cytokine induced suppression of synthesis, albumin catabolism, dilutional and 3rd space losses. Adverse px but poor sensitivity and specificity  Procalcitonin: plasma marker of sepsis. Septic vs nonseptic, not specific
  • 25. Hemodynamic monitors of tissue perfusion  Global  SvO2/ ScvO2>70%  Esophageal Doppler probe…measure CO during resuscitation after trauma  Regional perfusion  Gastric tonometry PHi and PCO2  Siblingual capnometry
  • 26. Modifiable  Delay in resuscitation  Amount of RBC transfusion  Age of transfused products  High base deficit  Uncorrected lactate at 12- 24hrs post injury  Abdominal compartment syndrome  Missed injury Non modifiable  High injury severity  Age >55years old  Obesity  Male gender  Genetics  Comorbidities Predictors of MOF
  • 27. Biomarker Disease conditions Role Neutrophil gelatinase- Lipocalin (NGAL) acute kidney injury Detects 36-48hrs earlier than creatinine Serum glutamate/glutamine Sepsis Marks liver dysfunction Cytokeratin-18 (CK-18) Sepsis with hepatic dysfunction Early predictor of survival Procalcitonin (PCT) Sepsis and infection Early marker Adrenomedullin (AM) Acute cardiac injury Elevated in early septic shock Pentraxin-3 (PTX3) Acute lung and heart injury Correlate with severity NT-pro-BNP severe sepsis and septic shock Marks myocardial dysfunction VCAM-1(vascular cell adhesion molecule 1) Mediates adhesion of cells to endothelium Cytokines (interleukine; IL) 6 Myocardial disfunction Predictor of mortality Endothelial cell-specific molecule 1 (ESM-1 sepsis Endocan increase indicate poor prognosis
  • 28. Scoring of MOF  No gold standard system Most organ failure assessment systems assign values to six organ systems  Respiratory  Cardiovascular  Renal  Hematology,  Hepatic  Central nervous system  Sauaia et al. reported Denver and Marshall MODS perform well as indicators of unfavorable outcomes in critically ill patients
  • 29. Marshall MOF scores  Evaluate 6 systems each scored 0-4  Parameters recorded at same time of day always  Does not consider specific values as indicators of MOF  Establishes degree of severity defined by observed mortality
  • 30.  Denver scale evaluates  4 systems each scored 0-3  OF defined as score>0 , MOF is defined as failure of 2 or more organs with score of 4 or more as determined 48hrs after trauma Ciesla et al, The role of the lung in postinjury multiple organ failure Surgery 01-OCT-2005; 138(4): 749-57
  • 31. Management principles  Early aggressive resuscitation and physiologic monitoring  Avoid additional insults and control sources  Prevent nosocomial infection  Supportive therapy for dysfunctional organ  Glycemic control and early enteral nutrition  Prophylaxis: DVT , Stress ulcer  Minimize blood transfusion when possible  Use agents that can disrupt end organ injury  Activated protein C Current Therapy of Trauma and Surgical Critical Care eds Asensio and Trunkey 2008
  • 32. Prognosis of MOF Depends on  Number of failing organs  MR 27-100%  Duration of organ dysfunction  Advanced age  Premorbid illness Knaus
  • 33. References  Mastery of Surgery, 5th Edition  ACS surgery: principles and practices, 2007 edition  Subston text book of surgery, 19th edition  International Journal of Clinical Medicine, 2012, 3, 722-730  de Montmollin and Annane Critical Care2011, 15:236  Can J Surg, Vol. 51, No. 2, April 2008  EDWIN A. DEITCH, M.D.

Editor's Notes

  1. Th e authors showed that LOX-1 neutraliza tion reduced endotoxin-induced leukocyte adher ence and reduced plasma levels of monocyte chemoattractant protein-1 (MCP-1), a major chemokine.